Key facts
- It has raised $11.3M across 1 recorded rounds; the latest was Seed Round ($650K) in Apr 2024.
- Notable investors include Ascension AI, Confluence Capital Group, GranCorp Holdings.
- Aiberry has filed 4 Form Ds with the SEC since 2020, most recently Jun 2025 ( sold).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Aiberry
Funding rounds
1 roundsAbout Aiberry
Developer of an artificial intelligence-powered screening platform designed for the detection of mental health and brain-related disorders. The company's platform connects doctors, physicians, counselors, and insurance providers with patients for the evaluation, detection, and monitoring of mental health disorders and analyzes patients' words, audio and visual features during a short conversation to deliver a quantified risk score and health insights to providers in real-time, enabling healthcare providers to make sound clinical decisions and achieve relevant treatment outcomes for their patients in real-time.
- Sector
- Healthcare
- HQ
- Bellevue, WA, United States
- Founded
- 2019
- Employees
- 12
- Website
- aiberry.com/
- Ownership
- Privately Held (backing)
Aiberry doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aiberry shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aiberry in its N-PORT filings yet. We sweep new filings monthly.